You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. On-Chip Passive Phase-Locking for High Coherent Power, Mid-IR Quantum Cascade Lasers

    SBC: INTRABAND, LLC            Topic: A10aT007

    The technical objectives of this proposal are: 1) Implement the design developed in Phase I for the realization of 8 micron-emitting active-photonic-crystal (APC) quantum-cascade (QC) lasers of 3 W average, diffraction-limited power and 15 % wallplug efficiency in quasi-CW operation; 2) Design and realize 4.6 micron-emitting APC QC lasers of 3 W CW diffraction-limited power and 15 % wallplug effic ...

    STTR Phase II 2012 Department of DefenseArmy
  2. Deep ultraviolet laser for Raman spectroscopy

    SBC: TIPD LLC            Topic: A11aT005

    The Phase II program proposes to commercialize frequency quadrupling technology developed in the College of Optical Sciences at the University of Arizona to build a 244 nm UV frequency quadrupled optically pumped semiconductor laser (FQ-OPSL). The laser will provide a self-contained small footprint (

    STTR Phase II 2012 Department of DefenseArmy
  3. Whole-brain fluorescence and brightfield imaging at single-cell level

    SBC: DMetrix, Inc            Topic: NIA

    DESCRIPTION (provided by applicant): The goal of this project is to develop an open and flexible imaging platform capable of rapid, 0.5- 5 m pixel resolution image capture of large-area histology sections (up to 125 mm by 175 mm), in brightfield and by epi-fluorescence optical sectioning. The project involves state-of-the- art instrumentation development coupled with application programming inter ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  4. Point of Care Detection of Respiratory Viruses

    SBC: LUCIGEN CORPORATION            Topic: NIAID

    DESCRIPTION (provided by applicant): Respiratory infections have a significant health and economic impact worldwide. Current test products for the diagnosis of respiratory viral infections such as influenza are inadequate for the timely diagnosis needed for successful implementation of antiviral treatment. Unfortunately a test product that can accurately diagnose common respiratory viruses with hi ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  5. Random Shear Shuttle BAC Libraries for Antimicrobial Discovery from Soil Metageno

    SBC: LUCIGEN CORPORATION            Topic: NIAID

    DESCRIPTION (provided by applicant): 100,000 Americans perish each year due to untreatable bacterial infections. The societal benefits of new antibiotic compounds that are effective against numerous multiple drug resistant pathogens would be significant. The best possible source for new antibiotic structures with potentially novel mechanisms of action is within natural environments, particularly s ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  6. Engineered tissue-based, high-throughput compound profiling

    SBC: Invivosciences, Inc.            Topic: NIGMS

    DESCRIPTION (provided by applicant): Current NIGMS-SBIR funding supported InvivoSciences LLC's (IVS) launch of several product lines in 2010. IVS generated revenues from the sales of three-dimensional (3D) cell culture tools (MC-8TM and IVS InsertsTM) thatcan grow various hydrogel tissues without any support layers. The culture tools enable Palpator TM and Tissue StretcherTM to stretch the hy ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  7. NOVEL SOLUBILITY-ENHANCING PROTEIN EXPRESSION TECHNOLOGY

    SBC: LUCIGEN CORPORATION            Topic: NIGMS

    DESCRIPTION (provided by applicant): A major goal in the post-genomic era is to express the vast collection of protein- coding sequences, eventually resulting in a better understanding of protein interactions and the development of novel therapeutics. Themost favored host for heterologous recombinant protein expression is Escherichia coli. Despite many improvements, producing soluble proteins in E ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  8. Intelligent Prosthetic Socket with Variable Volume and Elevated Vacuum Systems

    SBC: SMART SURFACE DESIGNS, LLC            Topic: NICHD

    DESCRIPTION (provided by applicant): Patient socket performance is a critical barrier to progress in rehabilitation, the most common source of patient dissatisfaction and part of a growing medical and socioeconomic problem. Poor socket performance is a greatly uncharacterized multi-factorial problem that leads to skin degeneration and patient discomfort (~75% of all patients). This proposal has a ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  9. Screening Device for Differentiated Primary Cell Models of Airway Epithelia

    SBC: Bellbrook Labs, LLC            Topic: NHLBI

    DESCRIPTION (provided by applicant): Approaches to drug screening typically involve dramatic compromises in order to achieve high throughput and hold down costs. Examples include the use of immortalized, heterologous cell lines, and genetic engineering toover-express the target protein and/or incorporate a fluorescent surrogate reporter to display the result. At least partly because such systems o ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  10. Targeting System Xc- for the Treatment of Schizophrenia

    SBC: Promentis Pharmaceuticals            Topic: NIMH

    DESCRIPTION (provided by applicant): Schizophrenia is a chronic and debilitating disorder that impacts nearly 1% of the world's population. The burden on the families and caregivers of patients is immense, with the cost of care in the United States being greater than 60 billion annually. The exorbitant financial strain of schizophrenia arises, in large part, to a lack of innovation that has ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government